Fairvalue-Calculator Fairvalue-Calculator
EN DE

OPKO Health, Inc (OPK) Fair Value & Analysis

Healthcare · US · Market cap $1.1B

Price$1.49
Fair Value$1.13
Upside-24.2%
Quality95/100
Evidence: Low Range $0.8400 – $1.68

Fair value as of: Jun 25, 2026

Analysis

OPKO Health, Inc (OPK) currently trades at $1.49, while our model-based Fair Value estimate is $1.13 — implying the stock looks roughly 24.2% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose and reduce body weight; NGENLA, recombinant human growth hormone product developed for the long-term treatment of pediatric patients with growth hormone deficiency. The Diagnostics segment offers la…

Open the full interactive analysis →

Similar stocks

Thermo Fisher Scientific Inc (TMO) -60% Danaher Corporation (DHR) -52% WuXi AppTec Co (WUXAY) +35% IDEXX Laboratories, Inc (IDXX) -66% Lonza Group (LZAGY) -77% Agilent Technologies, Inc (A) -54%

Frequently asked questions

Is OPKO Health, Inc (OPK) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $1.13 versus a price of $1.49 — about −24% (overvalued). Model-based estimate, not financial advice.
What is the fair value of OPK?
Our 21-model fair value for OPKO Health, Inc is $1.13 (as of Jun 25, 2026), built from audited fundamentals. The current price is $1.49.
What is the quality score of OPK?
OPKO Health, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.